ASEP Medical Holdings Inc. SEPSF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.38% | -35.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.38% | -35.24% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 0.38% | -35.24% | |||
| SG&A Expenses | 30.17% | -46.97% | |||
| Depreciation & Amortization | -0.88% | -40.72% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 24.91% | -51.68% | |||
| Operating Income | -30.68% | 54.40% | |||
| Income Before Tax | -152.46% | 94.09% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -134.19% | 94.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 238.46% | -99.13% | |||
| Net Income | -126.71% | 89.84% | |||
| EBIT | -30.68% | 54.40% | |||
| EBITDA | -47.39% | 59.36% | |||
| EPS Basic | -72.63% | 89.84% | |||
| Normalized Basic EPS | 18.84% | -111.72% | |||
| EPS Diluted | -72.63% | 89.84% | |||
| Normalized Diluted EPS | 18.84% | -111.72% | |||
| Average Basic Shares Outstanding | 31.46% | -0.02% | |||
| Average Diluted Shares Outstanding | 31.46% | -0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||